Search results
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 1 day agoAstrazeneca (AZN) AstraZeneca plc, headquartered in London, UK, is one of the largest...
AstraZeneca (LON:AZN) Given New £150 Price Target at Berenberg Bank
ETF DAILY NEWS· 6 days agoAstraZeneca (LON:AZN – Get Free Report) had its target price increased by equities research analysts at Berenberg Bank from £130 ($166.56) to £150 ($192.18) in a research ...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 5 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
... Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails - AstraZeneca (NASDAQ:AZN), AbbVie...
Benzinga· 1 day agoPfizer's PFE phase III study of investigational gene therapy, fordadistrogene movaparvovec, for...
AstraZeneca champions early kidney disease diagnosis with modelling data
Pharmaceutical Technology via Yahoo Finance· 3 days agoAstraZeneca has highlighted both the economic and environmental benefits of implementing early,...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 2 days agoAstraZeneca (AZN) has long been in the oncology and other disease spaces, but rose to popularity in...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 2 days agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 3 days agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing...